via Medical Xpress
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined “liquid biopsy,” epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages.
The findings, published online today in Nature, describe not only a way to detect cancer, but hold promise of being able to find it earlier when it is more easily treated and long before symptoms ever appear, says Dr. De Carvalho, Senior Scientist at the cancer centre, University Health Network.
“We are very excited at this stage,” says Dr. De Carvalho. “A major problem in cancer is how to detect it early. It has been a ‘needle in the haystack’ problem of how to find that one-in-a-billion cancer-specific mutation in the blood, especially at earlier stages, where the amount of tumour DNA in the blood is minimal.”
By profiling epigenetic alterations instead of mutations, the team was able to identify thousands of modifications unique to each cancer type. Then, using a big data approach, they applied machine learning to create classifiers able to identify the presence of cancer-derived DNA within blood samples and to determine what cancer type. This basically turns the “one needle in the haystack” problem into a more solvable “thousands of needles in the haystack,” where the computer just needs to find a few needles to define which haystack has needles.
The scientists tracked the cancer origin and type by comparing 300 patient tumour samples from seven disease sites (lung, pancreatic, colorectal, breast, leukemia, bladder and kidney) and samples from healthy donors with the analysis of cell-free DNA circulating in the blood plasma. In every sample, the “floating” plasma DNA matched the tumour DNA. The team has since expanded the research and has now profiled and successfully matched more than 700 tumour and blood samples from more cancer types.
Beyond the lab, next steps to further validate this approach include analysing data from large population health research studies already under way in several countries, where blood samples were collected months to years before cancer diagnosis. Then the approach will need to be ultimately validated in prospective studies for cancer screening.
Learn more:Â A NEW APPROACH TO DETECTING CANCER EARLIER FROM BLOOD TESTS: STUDY
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- COVID-19 vaccine effectiveness wanes more quickly in cancer patients, study findson May 24, 2022 at 7:13 pm
A study co-led by the Universities of Oxford, Birmingham and Southampton and the UK Health Security Agency (UKHSA), published in Lancet Oncology today by the UK Coronavirus Cancer Evaluation Project, ...
- I Was Blindsided by a Cancer I’ve Never Heard Ofon May 24, 2022 at 1:25 pm
I was told that I would miscarry my pregnancy, but continued to feel more pregnant, leading to my molar pregnancy diagnosis — a condition I’ve never heard of before.
- 'I Discovered Red 'Dots' On My Skin, a Day Later I Was Diagnosed With a Rare Cancer'on May 24, 2022 at 11:21 am
I want to be a dentist in the future, so in late 2021 I was at college in Florida doing pre-dental courses. I was balancing a lot because I was also on the basketball team and often had practice right ...
- Can kidney cancer be mistaken for kidney stones?on May 24, 2022 at 5:08 am
Kidney stones share some symptoms with kidney cancer. Learn more about whether cancer can be mistaken for kidney stones.
- Simple blood test could save thousands from bowel canceron May 19, 2022 at 5:36 am
Comparisons with other tests available have shown that blood test has greater sensitivity for the detection of bowel cancer ...
- Standard blood cancer test holds clear clues of rare IgD multiple myelomaon May 18, 2022 at 10:03 pm
A test for the common blood cancer multiple myeloma also holds clear clues that the patient has one of the most uncommon and deadly forms of this cancer, investigators say.
- Standard test for multiple myeloma provides clues of a rare, more deadly typeon May 18, 2022 at 9:03 pm
A test for the common blood cancer multiple myeloma also holds clear clues that the patient has one of the most uncommon and deadly forms of this cancer, investigators say.
- Simple blood test could save thousands of lives from bowel canceron May 18, 2022 at 7:17 am
A simple blood test that detects bowel cancer earlier is one step closer to being available on the NHS after showing excellent results in a trial. The Raman Spectrometry (RS) blood test has been ...
- If You Have This Blood Type, Be Worried About Canceron May 18, 2022 at 5:46 am
There's been several studies that indicate people with certain blood types are at greater risk for GI related cancers.
via Bing News